Every barrier tissue in your body moves molecules by one of two fundamental routes: the transcellular pathway, which goes straight through individual cells, and the paracellular pathway, which squeezes between neighboring cells through the narrow gaps sealed by protein complexes called tight junctions. The distinction matters far more than it sounds, because which route a substance takes determines what reaches your blood, your brain, and your organs. Understanding these two pathways helps explain everything from how you absorb nutrients to why most drugs can’t reach the brain and why a “leaky gut” is more than a wellness buzzword.
Two Routes Through One Sheet of Cells
Picture the lining of your intestine, or the walls of the tiny blood vessels in your brain, as a tiled floor. Each tile is a cell. Transcellular transport means a molecule enters one side of a tile, crosses through the interior, and exits the other side. Paracellular transport means the molecule slips through the grout lines between tiles. Both routes accomplish the same end goal — getting something from one side of a cell layer to the other — but they obey completely different rules about what can pass.
Transcellular transport is selective and energy-hungry. A molecule either dissolves through the cell’s fatty outer membrane (if it’s lipophilic enough), gets carried by a specific transporter protein, or gets swallowed whole by the cell in a bubble of membrane through a process called endocytosis. Each of these sub-routes adds specificity: transporters only accept molecules of the right shape, and endocytosis often requires a molecule to dock with a receptor first. The cell controls what gets in.
Paracellular transport, by contrast, is passive and relatively unselective. It doesn’t require a cell to do anything. Instead, water, ions, and small water-soluble molecules drift between cells, driven by concentration gradients and electrical charge differences. The gatekeepers here are the tight junctions, multi-protein seals made of proteins like claudins, occludin, and zonula occludens. These junctions aren’t simply locked doors — they contain size-selective and charge-selective channels. A 2023 review described two distinct paracellular sub-pathways: a “pore pathway” that lets small ions and water through size- and charge-selective channels, and a “leak pathway” that’s less selective but handles slightly larger molecules.1PubMed Central. Paracellular permeability and tight junction regulation in gut health and disease Between these two sub-routes and the transcellular options, a barrier tissue has a surprisingly nuanced toolkit for sorting what crosses and what doesn’t.
What Decides Which Route a Molecule Takes
The single biggest factor is a molecule’s relationship with fat and water. Lipophilic (fat-loving) molecules dissolve easily into cell membranes and tend to cross transcellularly. Hydrophilic (water-loving) molecules can’t get into the membrane, so they’re stuck with the paracellular cracks or need a transporter to carry them. Research on Caco-2 cell monolayers — the standard lab model of the intestinal lining — has shown that passive transcellular permeability can be predicted from just two properties: a compound’s fat-water distribution coefficient and its molecular weight.2PubMed. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs’ lipophilicity and molecular weight Hydrogen-bonding capacity also matters: compounds with lots of hydrogen-bond donors and acceptors struggle to shed their water shell and enter the fatty membrane, so they tend to stay hydrophilic and take paracellular routes or rely on carriers.3Pharmaceutical Science & Technology Today. Absorption prediction from physicochemical parameters
Size is the other constraint, especially for paracellular traffic. The pore pathway handles molecules roughly the size of small ions and water. The leak pathway can pass somewhat larger solutes, but large proteins and macromolecules are essentially locked out of both paracellular routes under normal conditions. That’s a critical point for drug design: if your therapeutic molecule is large and water-soluble — like insulin or a monoclonal antibody — it can’t slip between cells, and it can’t dissolve through membranes. It needs an active transport mechanism or some formulation trick to get across.
In reality, many molecules use both routes simultaneously. Acidic drugs like salicylic acid, for instance, show a mix of passive diffusion and active carrier-mediated transport across intestinal cells, with the balance shifting depending on pH conditions on each side of the cell layer.4PubMed. pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers The body doesn’t enforce a strict either/or rule; it uses whichever path is available, and sometimes both at once.
The Gut as a Case Study
Your intestinal lining is the barrier tissue most people encounter conceptually, and it’s where the paracellular-versus-transcellular distinction gets especially interesting. Most nutrient absorption — amino acids, sugars, vitamins — happens transcellularly, using dedicated transporter proteins on the cell surface. Glucose, for example, is grabbed by sodium-glucose co-transporters on the side facing the gut lumen, moved through the cell, and released into the bloodstream on the other side. In humans and other large mammals, carrier-mediated transcellular absorption handles the bulk of glucose uptake.
But paracellular absorption isn’t negligible. In fact, comparative biology reveals a surprise: small flying animals like bats and songbirds absorb the majority of their glucose passively, presumably through paracellular routes, rather than through carrier-mediated transcellular paths.5Journal of Experimental Biology. Integrative physiology of transcellular and paracellular intestinal absorption The working theory is that their higher metabolic demands and proportionally larger intestinal surface area make a leakier paracellular pathway advantageous — more glucose gets through faster without the bottleneck of transporter saturation. In humans, the paracellular contribution to glucose absorption appears smaller, but it exists and may become more significant when transporter capacity is maxed out.
Water itself moves paracellularly in large quantities. Intestinal fluid absorption is driven by osmotic gradients created when transporters move sodium and glucose into the space between cells. Water follows that osmotic pull through the tight junctions. This is why oral rehydration therapy works: the glucose and sodium in the solution aren’t just replacing lost electrolytes — they’re actively pulling water paracellularly through the gut lining.
The Blood-Brain Barrier and Its Extreme Tight Junctions
If the intestinal lining is a moderately selective filter, the blood-brain barrier is a vault. The endothelial cells lining capillaries in the brain are connected by extraordinarily tight junctions that restrict paracellular permeability far more aggressively than in the gut or most other tissues.6PubMed Central. Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders These junctions block nearly all water-soluble molecules from entering the brain through the paracellular route. Even small ions have a hard time getting between brain capillary cells. The result is a brain environment that’s chemically isolated from fluctuations in your bloodstream — essential for stable neural signaling, but deeply frustrating for drug delivery.
The tight junctions serve to restrict blood-borne substances from entering the brain, which means nearly everything that does reach brain tissue has to go transcellularly.7PubMed. Blood-brain barrier tight junction permeability and ischemic stroke Small lipophilic molecules like caffeine or ethanol can dissolve through the endothelial membranes without assistance. But larger or more hydrophilic drugs — including most antibodies, chemotherapy agents, and gene therapies — need an active mechanism. This is where receptor-mediated transcytosis comes in: a therapeutic molecule is engineered to bind a receptor on the brain capillary endothelial cell, gets internalized in a vesicle, transported across the cell, and released on the brain side.8PubMed. Mechanisms of receptor-mediated transcytosis at the blood-brain barrier Designing ligands that trigger this process without being destroyed inside the cell is one of the most active areas in neuropharmacology.9PubMed. Receptor-mediated transcytosis of macromolecules across the blood-brain barrier
A more physical approach uses focused ultrasound with microbubbles to temporarily loosen tight junctions. Recent work in mice found that at lower ultrasound pressures, the opening is driven primarily by a transient reorganization of tight junction proteins — the junctions rearrange rather than break, and the effect reverses within hours.10PubMed Central. Safe focused ultrasound-mediated blood-brain barrier opening is driven primarily by transient reorganization of tight junctions This essentially converts a tiny patch of the blood-brain barrier from its default “almost no paracellular traffic” mode into something briefly closer to a normal capillary’s permeability, giving drugs a window to enter.
How the Kidneys Play Both Sides
The kidneys filter your entire blood volume dozens of times a day, and much of what’s filtered has to be reabsorbed before it becomes urine. In the proximal tubule — the first stretch of tube after filtration — reabsorption happens by both transcellular and paracellular flux working together.11Physiology. Understanding the Role of Paracellular Transport in the Proximal Tubule Transcellular transporters on the cell surface actively pump sodium, glucose, and amino acids from the filtered fluid back into the blood. This creates an osmotic gradient that pulls water paracellularly between the cells, and dissolved solutes like chloride hitch a ride with that water flow through a process called solvent drag.
Deeper in the kidney, in a region called the thick ascending limb of Henle’s loop, paracellular transport becomes even more sophisticated. The tight junctions there aren’t generic sieves — they’re built from specific claudin proteins that create cation-selective channels. Claudin-16 and claudin-19 form heteromeric complexes that prefer magnesium and calcium, creating the selectivity needed for paracellular reabsorption of these ions.12PubMed Central. Claudin-16 and claudin-19 function in the thick ascending limb Losing either protein in mice abolishes this cation selectivity, causing excessive magnesium wasting in the urine. In humans, mutations in the genes for these claudins cause a rare inherited condition with dangerously low magnesium and calcium levels.
Meanwhile, a separate claudin — claudin-10 — builds paracellular channels that favor sodium over magnesium. When researchers deleted claudin-10 from the thick ascending limb in mice, paracellular sodium permeability dropped, but calcium and magnesium reabsorption actually increased because the remaining junctions, now dominated by claudin-16/19 complexes, shifted selectivity toward divalent cations.13Proceedings of the National Academy of Sciences. Deletion of claudin-10 (Cldn10) in the thick ascending limb impairs paracellular sodium permeability and leads to hypermagnesemia and nephrocalcinosis The cells in this part of the kidney actually arrange their claudins in a mosaic pattern: some tight junctions carry claudin-10b and preferentially pass sodium, while neighboring junctions carry claudin-3/16/19 and preferentially pass magnesium. The result is that monovalent and divalent cations take physically separate paracellular routes through the same tissue, and their reabsorption can be regulated independently.14Proceedings of the National Academy of Sciences. Mosaic expression of claudins in thick ascending limbs of Henle results in spatial separation of paracellular Na+ and Mg2+ transport
Further down the kidney tubule, in the collecting duct, the emphasis shifts almost entirely to transcellular mechanisms. Here, aldosterone and vasopressin coordinate the activity of sodium channels on the cell’s apical side and sodium-potassium pumps on the basolateral side to fine-tune how much sodium your body retains.15PubMed Central. Coordinated Control of ENaC and Na+,K+-ATPase in Renal Collecting Duct This is where hormonal blood pressure regulation happens at the cellular level, and it’s almost entirely transcellular.
How Tight Junctions Get Loosened
Tight junctions aren’t static seals. They’re dynamic structures that can tighten or loosen in response to signals, and one of the central regulators of this process is an enzyme called myosin light chain kinase (MLCK). When activated, MLCK triggers contraction of a ring of contractile filaments that encircles each cell just below the tight junction.16PubMed Central. Myosin light chain kinase: pulling the strings of epithelial tight junction function This contraction physically tugs the cell borders apart, reorganizes the junction proteins, and increases paracellular permeability.17Journal of Cell Science. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure Inflammatory signals, particularly certain cytokines released by immune cells, activate MLCK. This explains why inflammation so reliably increases barrier leakiness: the immune system is literally loosening the grout between the tiles.
In the gut, this mechanism has direct relevance to inflammatory bowel disease. Patients with Crohn’s disease or ulcerative colitis show a loss of tight junction barrier function and increased paracellular permeability. The relationship between tight junction breakdown and disease activity remains a chicken-and-egg question — inflammation damages junctions, but increased permeability may also worsen immune activation by letting more gut contents across.18PubMed Central. Contributions of Myosin Light Chain Kinase to Regulation of Epithelial Paracellular Permeability and Mucosal Homeostasis The evidence suggests that tight junction defects alone aren’t enough to cause inflammatory bowel disease, but they alter the mucosal immune response in ways that may tip a genetically susceptible person toward disease.
Bacteria exploit this system, too. Many gut pathogens produce toxins that target tight junction proteins directly, essentially picking the lock on the paracellular gate. Clostridium perfringens enterotoxin, for example, binds directly to specific claudin proteins in the tight junction, using them as receptors to pry cells apart.19PubMed. Targeting and alteration of tight junctions by bacteria and their virulence factors such as Clostridium perfringens enterotoxin Other pathogens take a more indirect approach, hijacking the cell’s own cytoskeletal machinery to trigger junction opening.20PubMed. Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins From the bacterium’s perspective, breaking into the paracellular space gives it access to deeper tissues without needing to invade a cell.
Oral Drug Delivery and the Permeation Enhancer Problem
The pharmaceutical industry cares deeply about these two routes because most drugs are taken by mouth, and the intestinal barrier decides how much actually reaches the bloodstream. Small, moderately lipophilic drugs — think ibuprofen or caffeine — cross the intestinal epithelium transcellularly without much trouble. But large, hydrophilic molecules like peptides, proteins, and nucleic acid therapies are essentially locked out of both the transcellular and paracellular routes. This is why insulin still requires injection decades after its discovery: swallowed insulin gets degraded in the stomach and, even if some survives, can’t cross the intestinal barrier efficiently.
One approach to solving this is the use of permeation enhancers — compounds added to an oral formulation to temporarily increase intestinal permeability. Several hundred such compounds have been identified and tested.21PubMed Central. Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update Some work by loosening tight junctions (boosting paracellular transport), while others disrupt cell membranes (boosting transcellular transport). Experimental work using gut tissue has shown these two mechanisms produce visually distinct effects: a compound like EDTA, which chelates calcium needed for junction stability, increases paracellular passage and produces a characteristic “cobblestone” appearance as cell apices bulge outward. A surfactant like SDS, by contrast, makes cell membranes leaky and blocks normal endocytosis from the brush border — a transcellular effect.22PubMed Central. Probing paracellular versus transcellular tissue barrier permeability using a gut mucosal explant culture system The challenge is achieving enough permeability to get a therapeutic dose through without causing damage or letting harmful gut contents across at the same time.
Other Barriers Where Both Routes Matter
The paracellular-transcellular distinction plays out in tissues beyond the gut and brain. In the eye, the inner blood-retinal barrier uses tight junctions between retinal capillary endothelial cells to control what reaches the retina. Both transcellular and paracellular flux pathways operate here, and both are altered in diabetes, contributing to diabetic macular edema — fluid accumulation that threatens vision.23PubMed Central. The inner blood-retinal barrier: Cellular basis and development The integrity of this barrier depends on tight regulation of both transport routes to maintain the dry, stable environment the retina needs to function.24The FEBS Journal. The blood–retina barrier in health and disease
The placenta offers yet another variation. Maternal antibodies (IgG) cross the placenta to give the fetus passive immunity, but they don’t slip between cells. Instead, the syncytiotrophoblast — the continuous cell layer covering the placental villi — moves antibodies transcellularly using a specialized receptor called FcRn (the neonatal Fc receptor).25PubMed. Placental transport of immunoglobulin G This receptor-mediated transcytosis is selective for IgG’s molecular shape, which is why maternal IgG but not IgM or IgA transfers efficiently to the fetus. The paracellular route across the syncytiotrophoblast is essentially nonexistent under normal conditions because the tissue forms a true syncytium — cells fused together with no intercellular gaps — so there are no tight junctions to pass between.
Cancer, Junction Loss, and Metastasis
When cells lose their tight junctions and other adhesion structures, they become mobile. In normal development, this process — epithelial-mesenchymal transition — is essential for building complex tissues. But when it happens in an adult tumor, the consequences can be devastating. Cancer cells undergoing epithelial-mesenchymal transition downregulate their adhesion molecules, lose their connections to neighboring cells, and gain the ability to migrate away from the primary tumor.26PubMed Central. Holding Tight: Cell Junctions and Cancer Spread This is a core mechanism of metastasis. In a sense, the breakdown of the same paracellular barriers that normally keep tissues sealed is what lets cancer cells escape and colonize distant organs.
Microplastics and Emerging Threats to Barrier Integrity
The conversation about paracellular permeability is expanding into environmental health. Accumulating evidence suggests that microplastics ingested through food and water can disrupt intestinal epithelial barrier integrity and alter gut microbial balance, potentially triggering inflammatory responses that propagate beyond the gut.27PubMed Central. From the Gut to the Brain: Microplastic-Associated Neurovascular Dysfunction and Implications for Stroke Risk In a mouse study, exposure to polyethylene microplastics led to upregulation of tight junction protein genes in the duodenum, paradoxically suggesting that the body may attempt to tighten its barriers in response to the particles — yet the same mice showed reduced absorption of several minerals including calcium, copper, zinc, and manganese.28PubMed. Reduced dietary Ca, Cu, Zn, Mn, and Mg bioavailability but increased Fe bioavailability with polyethylene microplastic ingestion in a mouse model The research is still early-stage, mostly in animal models, but it points toward a future where understanding paracellular and transcellular dynamics becomes relevant not just to pharmacologists and gastroenterologists, but to environmental toxicologists as well.
How Researchers Measure These Pathways
Distinguishing paracellular from transcellular transport in a living tissue isn’t straightforward, since both routes deliver molecules to the same destination. The workhorse model for decades has been the Caco-2 cell monolayer — a human colon cancer cell line that, when grown on a permeable filter, differentiates into a sheet with functional tight junctions and transporter proteins. Researchers can put a test compound on one side and measure how fast it appears on the other, while also using inhibitors to tease apart whether transport is paracellular (blocked by junction-tightening agents), passive transcellular (predicted by lipophilicity), or carrier-mediated (saturable, sensitive to specific transporter inhibitors).29PubMed. Caco-2 cell permeability assays to measure drug absorption
Transepithelial electrical resistance, or TEER, is the most common real-time measure of tight junction integrity. A cell layer with tight junctions resists the flow of electrical current across it; the tighter the junctions, the higher the resistance. A sudden drop in TEER signals that paracellular permeability has increased — the junctions are opening. This measurement is used across research on cancer, drug absorption, and inflammation alike.30PubMed. Methods to examine tight junction physiology in cancer stem cells: TEER, paracellular permeability, and dilution potential measurements Fluorescent tracer molecules of known sizes offer another approach: a small tracer that appears on the other side of a monolayer with open junctions tells you about the pore pathway, while a large tracer that crosses only when membranes are disrupted points to transcellular leakage. By combining these tools, researchers can build a detailed picture of which pathway is doing what — and how disease, drugs, or environmental exposures change the balance.